Research Article

Prevalence of Hypertension and Its Associated Risk Factors among 34,111 HAART Naïve HIV-Infected Adults in Dar es Salaam, Tanzania

Table 3

Sociodemographic and clinical characteristics associated with hypertension.

ParameterAll 
= 34,111
Normotensive 
(%)
Hypertensive 
(%)
value

Age (years)<0.001
 <3077607131 (91.9%) 629 (8.1%)
 30–39148773289 (89.3%) 1588 (10.7%)
 40–4979646756 (84.8%) 1208 (15.2%)
 ≥5033172505 (75.5%) 813 (24.5%)
Gender<0.001
 Male111998423 (75.2%) 2776 (24.8%)
 Female2291221409 (93.4%) 1503 (6.6%)
BMI-defined obesity<0.001
 Underweight (BMI < 18.5 kg/m2)92358643 (93.6%) 592 (6.4%)
 Normal (BMI 18.5–24.9 kg/m2)1816015884 (87.5%) 2276 (12.5%)
 Overweight (BMI 25.0–29.9 kg/m2)43223440 (79.6%) 882 (20.4%)
 Obesity (BMI ≥ 30 kg/m2)16931228 (72.5%) 465 (27.5%)
CD4+ cell count (cells/µL)<0.001
 <350 2305020414 (88.6%) 2636 (11.4%)
 350–<500 37483177 (84.8%) 571 (15.2%)
 ≥500 37203120 (83.9%) 600 (16.1%)
WHO clinical disease stage<0.001
 Stage I49103982 (81.1%) 928 (18.9%)
 Stage II62285234 (84.0%) 994 (16.0%)
 Stage III1512813392 (88.5%) 1736 (11.5%)
 Stage IV66866139 (91.8%) 547 (8.2%)
History of TB<0.001
 Yes77396993 (90.4%) 746 (9.6%)
 No2553922097 (86.5%) 3442 (13.5%)
Current TB/HIV coinfection<0.001
 Yes32452940 (90.6%) 305 (9.4%)
 No3024626345 (87.1%) 3901 (12.9%)

BMI: body mass index; CD4+: cluster of differentiation 4; HIV: human immunodeficiency virus; TB: tuberculosis; WHO: World Health Organization.